A human pluripotent stem cell platform for assessing developmental neural toxicity screening
Stem Cell Research & Therapy2013Vol. 4(S1), pp. S12–S12
Citations Over TimeTop 13% of 2013 papers
Zhonggang Hou, Jue Zhang, Michael P. Schwartz, Ron Stewart, C. David Page, William L. Murphy, James A. Thomson
Abstract
A lack of affordable and effective testing and screening procedures mean surprisingly little is known about the health hazards of many of the tens of thousands of chemicals in use in the world today. The recent rise in the number of children affected by neurological disorders such as autism has stirred valuable debate about the role chemicals play in our daily life, highlighting the need for improved methods of assessing chemicals for developmental neural toxicity.
Related Papers
- → Preparation of Mouse Embryonic Fibroblasts as Feeders for iPSC Generation and Maintenance(2020)2 cited
- → The reprogramming therapy for a patient with advanced hepatocellular carcinoma by using human-induced pluripotent stem (iPS) cells technology(2013)3 cited
- The research advances on human induced pluripotent stem cells in vitro to produce red blood cells(2015)
- Abstract 20894: Therapeutic Efficacy of the Exosomes Derived From Human Induced Pluripotent Stem Cells (iPSCs) vs. Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes (iCMs) in Murine Myocardial Injury Model(2017)
- → Modeling Hypertrophic Cardiomyopathy with Human Induced Pluripotent Stem Cells(2016)